ALVO peer analysis
Alvotech (ALVO) against its competitors: price, today's move, 1-year return and market value side by side.
ALVO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMGN Amgen | $466.98 | -0.24% | 37.98% | $252.59B |
| AMPH Amphastar Pharmaceuticals | $28.86 | 0.91% | 6.26% | $1.23B |
| AMRX Amneal | $21.68 | -0.14% | 81.42% | $7.55B |
| BIIB Biogen | $250.52 | -1.14% | 57.01% | $37.03B |
| COLL Collegium | $24.98 | 0.69% | -44.29% | $776.26M |
| ETON Eton Pharmaceuticals | $61.37 | -10.28% | 247.51% | $1.77B |
| HROW Harrow | $28.30 | -3.63% | -26.94% | $1.06B |
| OGN Organon | $13.89 | 0.04% | 84.77% | $3.65B |
| REGN Regeneron | $953.91 | -0.57% | 41.41% | $98.66B |
| TEVA Teva | $43.66 | 0.97% | 73.74% | $50.94B |
| ALVO Alvotech | $4.68 | -4.88% | -16.13% | $1.67B |
- ALVO's peers: AMGN (Amgen), AMPH (Amphastar Pharmaceuticals), AMRX (Amneal), BIIB (Biogen), COLL (Collegium), ETON (Eton Pharmaceuticals), HROW (Harrow), OGN (Organon).
Updated 2026-11-13 04:50 UTC